CytoMed Therapeutics Limited ( GDTC) - Stock Earnings
GDTC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
GDTC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -622014 USD | 74520 USD |
| 2025Q2 | -694287 USD | 83179 USD |
| 2025Q4 | -1.0 million USD | 101539 USD |
GDTC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -2.4 million USD | 220003 USD |
| 2024 | -1.4 million USD | 38183 USD |
| 2025 | -2.4 million USD | 192989 USD |
| 2025 Est. | — | — |
GDTC
Price: $0.88
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.9 million